Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PuSH: Short Stay Aggressive Hydration for Preventing Post-ERCP Pancreatitis
NCT07776561Recruiting
- Sponsor
- Westmead Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of lactated ringer's solution in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (2 arms), sponsored by Westmead Hospital. Primary endpoint: Incidence of post-ERCP pancreatitis at 72 hours. Started Jun 2026; status: recruiting.
02
Drugs
lactated ringer's solution
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT07776561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07776561.